APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Eosinophilic Granulomatosis

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Eosinophilic Granulomatosis Industry Growth and Trends Forecast to 2032

Report ID 17398873012 January 2026100 pages

Choose your research edition.

Industry ResearchEosinophilic Granulomatosis Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Eosinophilic Granulomatosis Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Eosinophilic Granulomatosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Eosinophilic Granulomatosis Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Eosinophilic Granulomatosis Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Eosinophilic Granulomatosis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Eosinophilic Granulomatosis is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Eosinophilic Granulomatosis is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Eosinophilic Granulomatosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Eosinophilic Granulomatosis include Sanofi, Novartis International, GlaxoSmithKline, Baxter, Amgen, AstraZeneca, Pharmaceuticals Holdings, Genentech(Roche) and DSM, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Eosinophilic Granulomatosis market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Eosinophilic Granulomatosis market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Eosinophilic Granulomatosis market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Eosinophilic Granulomatosis.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Eosinophilic Granulomatosis market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Eosinophilic Granulomatosis Market by Company

Sanofi

Novartis International

GlaxoSmithKline

Baxter

Amgen

AstraZeneca

Pharmaceuticals Holdings

Genentech(Roche)

DSM

Cephalon(Teva)

Eosinophilic Granulomatosis Segment by Type

Oral

Intravenous

Others

Eosinophilic Granulomatosis Segment by Application

Hospital Pharmacies

Drug Stores

Others

Eosinophilic Granulomatosis Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Eosinophilic Granulomatosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Eosinophilic Granulomatosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Eosinophilic Granulomatosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Eosinophilic Granulomatosis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Eosinophilic Granulomatosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Table 2. Major Company of Intravenous Table 3. Major Company of Others Table 4. Global Eosinophilic Granulomatosis Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Eosinophilic Granulomatosis Sales by Type (2021-2026) & (Tons) Table 6. Global Eosinophilic Granulomatosis Sales Market Share in Volume by Type (2021-2026) Table 7. Global Eosinophilic Granulomatosis Sales by Type (2021-2026) & (US$ Million) Table 8. Global Eosinophilic Granulomatosis Sales Market Share in Value by Type (2021-2026) Table 9. Global Eosinophilic Granulomatosis Price by Type (2021-2026) & (US$/Ton) Table 10. Global Eosinophilic Granulomatosis Sales by Type (2027-2032) & (Tons) Table 11. Global Eosinophilic Granulomatosis Sales Market Share in Volume by Type (2027-2032) Table 12. Global Eosinophilic Granulomatosis Sales by Type (2027-2032) & (US$ Million) Table 13. Global Eosinophilic Granulomatosis Sales Market Share in Value by Type (2027-2032) Table 14. Global Eosinophilic Granulomatosis Price by Type (2027-2032) & (US$/Ton) Table 15. North America Eosinophilic Granulomatosis Sales by Type (2021-2026) & (Tons) Table 16. North America Eosinophilic Granulomatosis Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Eosinophilic Granulomatosis Sales by Type (2021-2026) & (Tons) Table 18. Europe Eosinophilic Granulomatosis Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Eosinophilic Granulomatosis Sales by Type (2021-2026) & (Tons) Table 20. Asia-Pacific Eosinophilic Granulomatosis Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Eosinophilic Granulomatosis Sales by Type (2021-2026) & (Tons) Table 22. Latin America Eosinophilic Granulomatosis Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Eosinophilic Granulomatosis Sales by Type (2021-2026) & (Tons) Table 24. Middle East and Africa Eosinophilic Granulomatosis Sales by Type (2021-2026) & (US$ Million) Table 25. Eosinophilic Granulomatosis Industry Trends Table 26. Eosinophilic Granulomatosis Industry Drivers Table 27. Eosinophilic Granulomatosis Industry Opportunities and Challenges Table 28. Eosinophilic Granulomatosis Industry Restraints Table 29. Global Eosinophilic Granulomatosis Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Eosinophilic Granulomatosis Revenue Market Share by Company (2021-2026) Table 31. Global Eosinophilic Granulomatosis Sales by Company (2021-2026) & (Tons) Table 32. Global Eosinophilic Granulomatosis Sales Share by Company (2021-2026) Table 33. Global Eosinophilic Granulomatosis Market Price by Company (2021-2026) & (US$/Ton) Table 34. Global Eosinophilic Granulomatosis Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Eosinophilic Granulomatosis Major Company Production Sites and Headquarters Table 36. Global Eosinophilic Granulomatosis Company, Product Type & Application Table 37. Global Eosinophilic Granulomatosis Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Eosinophilic Granulomatosis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Eosinophilic Granulomatosis Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Eosinophilic Granulomatosis Sales by Region (2021-2026) & (Tons) Table 42. Global Eosinophilic Granulomatosis Sales Market Share in Volume by Region (2021-2026) Table 43. Global Eosinophilic Granulomatosis Sales by Region (2021-2026) & (US$ Million) Table 44. Global Eosinophilic Granulomatosis Sales Market Share in Value by Region (2021-2026) Table 45. Global Eosinophilic Granulomatosis Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 46. Global Eosinophilic Granulomatosis Sales by Region (2027-2032) & (Tons) Table 47. Global Eosinophilic Granulomatosis Sales Market Share in Volume by Region (2027-2032) Table 48. Global Eosinophilic Granulomatosis Sales by Region (2027-2032) & (US$ Million) Table 49. Global Eosinophilic Granulomatosis Sales Market Share in Value by Region (2027-2032) Table 50. Global Eosinophilic Granulomatosis Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 51. Global Eosinophilic Granulomatosis Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Eosinophilic Granulomatosis Sales by Application (2021-2026) & (Tons) Table 53. Global Eosinophilic Granulomatosis Sales Market Share in Volume by Application (2021-2026) Table 54. Global Eosinophilic Granulomatosis Sales by Application (2021-2026) & (US$ Million) Table 55. Global Eosinophilic Granulomatosis Sales Market Share in Value by Application (2021-2026) Table 56. Global Eosinophilic Granulomatosis Price by Application (2021-2026) & (US$/Ton) Table 57. Global Eosinophilic Granulomatosis Sales by Application (2027-2032) & (Tons) Table 58. Global Eosinophilic Granulomatosis Sales Market Share in Volume by Application (2027-2032) Table 59. Global Eosinophilic Granulomatosis Sales by Application (2027-2032) & (US$ Million) Table 60. Global Eosinophilic Granulomatosis Sales Market Share in Value by Application (2027-2032) Table 61. Global Eosinophilic Granulomatosis Price by Application (2027-2032) & (US$/Ton) Table 62. North America Eosinophilic Granulomatosis Sales by Application (2021-2026) & (Tons) Table 63. North America Eosinophilic Granulomatosis Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Eosinophilic Granulomatosis Sales by Application (2021-2026) & (Tons) Table 65. Europe Eosinophilic Granulomatosis Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Eosinophilic Granulomatosis Sales by Application (2021-2026) & (Tons) Table 67. Asia-Pacific Eosinophilic Granulomatosis Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Eosinophilic Granulomatosis Sales by Application (2021-2026) & (Tons) Table 69. Latin America Eosinophilic Granulomatosis Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Eosinophilic Granulomatosis Sales by Application (2021-2026) & (Tons) Table 71. Middle East and Africa Eosinophilic Granulomatosis Sales by Application (2021-2026) & (US$ Million) Table 72. Sanofi Company Information Table 73. Sanofi Business Overview Table 74. Sanofi Eosinophilic Granulomatosis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Sanofi Eosinophilic Granulomatosis Product Portfolio Table 76. Sanofi Recent Development Table 77. Novartis International Company Information Table 78. Novartis International Business Overview Table 79. Novartis International Eosinophilic Granulomatosis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Novartis International Eosinophilic Granulomatosis Product Portfolio Table 81. Novartis International Recent Development Table 82. GlaxoSmithKline Company Information Table 83. GlaxoSmithKline Business Overview Table 84. GlaxoSmithKline Eosinophilic Granulomatosis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. GlaxoSmithKline Eosinophilic Granulomatosis Product Portfolio Table 86. GlaxoSmithKline Recent Development Table 87. Baxter Company Information Table 88. Baxter Business Overview Table 89. Baxter Eosinophilic Granulomatosis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Baxter Eosinophilic Granulomatosis Product Portfolio Table 91. Baxter Recent Development Table 92. Amgen Company Information Table 93. Amgen Business Overview Table 94. Amgen Eosinophilic Granulomatosis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Amgen Eosinophilic Granulomatosis Product Portfolio Table 96. Amgen Recent Development Table 97. AstraZeneca Company Information Table 98. AstraZeneca Business Overview Table 99. AstraZeneca Eosinophilic Granulomatosis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. AstraZeneca Eosinophilic Granulomatosis Product Portfolio Table 101. AstraZeneca Recent Development Table 102. Pharmaceuticals Holdings Company Information Table 103. Pharmaceuticals Holdings Business Overview Table 104. Pharmaceuticals Holdings Eosinophilic Granulomatosis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. Pharmaceuticals Holdings Eosinophilic Granulomatosis Product Portfolio Table 106. Pharmaceuticals Holdings Recent Development Table 107. Genentech(Roche) Company Information Table 108. Genentech(Roche) Business Overview Table 109. Genentech(Roche) Eosinophilic Granulomatosis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 110. Genentech(Roche) Eosinophilic Granulomatosis Product Portfolio Table 111. Genentech(Roche) Recent Development Table 112. DSM Company Information Table 113. DSM Business Overview Table 114. DSM Eosinophilic Granulomatosis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 115. DSM Eosinophilic Granulomatosis Product Portfolio Table 116. DSM Recent Development Table 117. Cephalon(Teva) Company Information Table 118. Cephalon(Teva) Business Overview Table 119. Cephalon(Teva) Eosinophilic Granulomatosis Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 120. Cephalon(Teva) Eosinophilic Granulomatosis Product Portfolio Table 121. Cephalon(Teva) Recent Development Table 122. North America Eosinophilic Granulomatosis Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 123. North America Eosinophilic Granulomatosis Sales by Country (2021-2026) & (Tons) Table 124. North America Eosinophilic Granulomatosis Sales Market Share by Country (2021-2026) Table 125. North America Eosinophilic Granulomatosis Sales Forecast by Country (2027-2032) & (Tons) Table 126. North America Eosinophilic Granulomatosis Sales Market Share Forecast by Country (2027-2032) Table 127. North America Eosinophilic Granulomatosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Eosinophilic Granulomatosis Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Eosinophilic Granulomatosis Market Share by Country (2021-2026) Table 130. North America Eosinophilic Granulomatosis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Eosinophilic Granulomatosis Market Share Forecast by Country (2027-2032) Table 132. Europe Eosinophilic Granulomatosis Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 133. Europe Eosinophilic Granulomatosis Sales by Country (2021-2026) & (Tons) Table 134. Europe Eosinophilic Granulomatosis Sales Market Share by Country (2021-2026) Table 135. Europe Eosinophilic Granulomatosis Sales Forecast by Country (2027-2032) & (Tons) Table 136. Europe Eosinophilic Granulomatosis Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Eosinophilic Granulomatosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Eosinophilic Granulomatosis Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Eosinophilic Granulomatosis Market Share by Country (2021-2026) Table 140. Europe Eosinophilic Granulomatosis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Eosinophilic Granulomatosis Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Eosinophilic Granulomatosis Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Eosinophilic Granulomatosis Sales by Country (2021-2026) & (Tons) Table 144. Asia-Pacific Eosinophilic Granulomatosis Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Eosinophilic Granulomatosis Sales Forecast by Country (2027-2032) & (Tons) Table 146. Asia-Pacific Eosinophilic Granulomatosis Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Eosinophilic Granulomatosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Eosinophilic Granulomatosis Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Eosinophilic Granulomatosis Market Share by Country (2021-2026) Table 150. Asia-Pacific Eosinophilic Granulomatosis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Eosinophilic Granulomatosis Market Share Forecast by Country (2027-2032) Table 152. Latin America Eosinophilic Granulomatosis Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 153. Latin America Eosinophilic Granulomatosis Sales by Country (2021-2026) & (Tons) Table 154. Latin America Eosinophilic Granulomatosis Sales Market Share by Country (2021-2026) Table 155. Latin America Eosinophilic Granulomatosis Sales Forecast by Country (2027-2032) & (Tons) Table 156. Latin America Eosinophilic Granulomatosis Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Eosinophilic Granulomatosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Eosinophilic Granulomatosis Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Eosinophilic Granulomatosis Market Share by Country (2021-2026) Table 160. Latin America Eosinophilic Granulomatosis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Eosinophilic Granulomatosis Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Eosinophilic Granulomatosis Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Eosinophilic Granulomatosis Sales by Country (2021-2026) & (Tons) Table 164. Middle East and Africa Eosinophilic Granulomatosis Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Eosinophilic Granulomatosis Sales Forecast by Country (2027-2032) & (Tons) Table 166. Middle East and Africa Eosinophilic Granulomatosis Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Eosinophilic Granulomatosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Eosinophilic Granulomatosis Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Eosinophilic Granulomatosis Market Share by Country (2021-2026) Table 170. Middle East and Africa Eosinophilic Granulomatosis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Eosinophilic Granulomatosis Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Eosinophilic Granulomatosis Distributors List Table 175. Eosinophilic Granulomatosis Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Eosinophilic Granulomatosis Image Figure 2. Global Eosinophilic Granulomatosis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Eosinophilic Granulomatosis Market Size (2021-2032) & (US$ Million) Figure 4. Global Eosinophilic Granulomatosis Sales (2021-2032) & (Tons) Figure 5. Oral Image Figure 6. Global Oral Sales YoY Growth (2021-2032) & (Tons) Figure 7. Intravenous Image Figure 8. Global Intravenous Sales YoY Growth (2021-2032) & (Tons) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 11. Global Eosinophilic Granulomatosis Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Eosinophilic Granulomatosis Market Share by Type 2025 VS 2032 Figure 13. North America Eosinophilic Granulomatosis Sales Market Share in Volume by Type in 2025 Figure 14. North America Eosinophilic Granulomatosis Sales Market Share in Value by Type in 2025 Figure 15. Europe Eosinophilic Granulomatosis Sales Market Share in Volume by Type in 2025 Figure 16. Europe Eosinophilic Granulomatosis Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Eosinophilic Granulomatosis Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Eosinophilic Granulomatosis Sales Market Share in Value by Type in 2025 Figure 19. Latin America Eosinophilic Granulomatosis Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Eosinophilic Granulomatosis Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Eosinophilic Granulomatosis Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Eosinophilic Granulomatosis Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Eosinophilic Granulomatosis Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Pharmacies Image Figure 26. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (Tons) Figure 27. Drug Stores Image Figure 28. Global Drug Stores Sales YoY Growth (2021-2032) & (Tons) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 31. Global Eosinophilic Granulomatosis Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Eosinophilic Granulomatosis Market Share by Application 2025 VS 2032 Figure 33. North America Eosinophilic Granulomatosis Sales Market Share in Volume by Application in 2025 Figure 34. North America Eosinophilic Granulomatosis Sales Market Share in Value by Application in 2025 Figure 35. Europe Eosinophilic Granulomatosis Sales Market Share in Volume by Application in 2025 Figure 36. Europe Eosinophilic Granulomatosis Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Eosinophilic Granulomatosis Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Eosinophilic Granulomatosis Sales Market Share in Value by Application in 2025 Figure 39. Latin America Eosinophilic Granulomatosis Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Eosinophilic Granulomatosis Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Eosinophilic Granulomatosis Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Eosinophilic Granulomatosis Sales Market Share in Value by Application in 2025 Figure 43. North America Eosinophilic Granulomatosis Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 44. North America Eosinophilic Granulomatosis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Eosinophilic Granulomatosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Eosinophilic Granulomatosis Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Eosinophilic Granulomatosis Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. Europe Eosinophilic Granulomatosis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Eosinophilic Granulomatosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Eosinophilic Granulomatosis Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Eosinophilic Granulomatosis Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Asia-Pacific Eosinophilic Granulomatosis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Eosinophilic Granulomatosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Eosinophilic Granulomatosis Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Eosinophilic Granulomatosis Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Latin America Eosinophilic Granulomatosis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Eosinophilic Granulomatosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Eosinophilic Granulomatosis Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Eosinophilic Granulomatosis Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 60. Middle East and Africa Eosinophilic Granulomatosis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Eosinophilic Granulomatosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Eosinophilic Granulomatosis Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Eosinophilic Granulomatosis Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Eosinophilic Granulomatosis Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Intravenous
  • Others
Applications
  • Hospital Pharmacies
  • Drug Stores
  • Others
Companies covered
  • Sanofi
  • Novartis International
  • GlaxoSmithKline
  • Baxter
  • Amgen
  • AstraZeneca
  • Pharmaceuticals Holdings
  • Genentech(Roche)
  • DSM
  • Cephalon(Teva)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Eosinophilic Granulomatosis Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Eosinophilic Granulomatosis Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Eosinophilic Granulomatosis Market by Type
  6. 1.3.1 Oral
  7. 1.3.2 Intravenous
  8. 1.3.3 Others
  9. 1.4 Global Eosinophilic Granulomatosis Market Size by Type
  10. 1.4.1 Global Eosinophilic Granulomatosis Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Eosinophilic Granulomatosis Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Eosinophilic Granulomatosis Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Eosinophilic Granulomatosis Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Eosinophilic Granulomatosis Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Eosinophilic Granulomatosis Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Eosinophilic Granulomatosis Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Eosinophilic Granulomatosis Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Eosinophilic Granulomatosis Industry Trends
  2. 2.2 Eosinophilic Granulomatosis Industry Drivers
  3. 2.3 Eosinophilic Granulomatosis Industry Opportunities and Challenges
  4. 2.4 Eosinophilic Granulomatosis Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Eosinophilic Granulomatosis Revenue (2021-2026)
  2. 3.2 Global Top Players by Eosinophilic Granulomatosis Sales (2021-2026)
  3. 3.3 Global Top Players by Eosinophilic Granulomatosis Price (2021-2026)
  4. 3.4 Global Eosinophilic Granulomatosis Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Eosinophilic Granulomatosis Major Company Production Sites & Headquarters
  6. 3.6 Global Eosinophilic Granulomatosis Company, Product Type & Application
  7. 3.7 Global Eosinophilic Granulomatosis Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Eosinophilic Granulomatosis Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Eosinophilic Granulomatosis Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Eosinophilic Granulomatosis Tier 1, Tier 2, and Tier 3
4 Eosinophilic Granulomatosis Regional Status and Outlook
  1. 4.1 Global Eosinophilic Granulomatosis Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Eosinophilic Granulomatosis Historic Market Size by Region
  3. 4.2.1 Global Eosinophilic Granulomatosis Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Eosinophilic Granulomatosis Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Eosinophilic Granulomatosis Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Eosinophilic Granulomatosis Forecasted Market Size by Region
  7. 4.3.1 Global Eosinophilic Granulomatosis Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Eosinophilic Granulomatosis Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Eosinophilic Granulomatosis Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Eosinophilic Granulomatosis by Application
  1. 5.1 Eosinophilic Granulomatosis Market by Application
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Drug Stores
  4. 5.1.3 Others
  5. 5.2 Global Eosinophilic Granulomatosis Market Size by Application
  6. 5.2.1 Global Eosinophilic Granulomatosis Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Eosinophilic Granulomatosis Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Eosinophilic Granulomatosis Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Eosinophilic Granulomatosis Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Eosinophilic Granulomatosis Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Eosinophilic Granulomatosis Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Eosinophilic Granulomatosis Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Eosinophilic Granulomatosis Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Eosinophilic Granulomatosis Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Eosinophilic Granulomatosis Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Novartis International
  8. 6.2.1 Novartis International Company Information
  9. 6.2.2 Novartis International Business Overview
  10. 6.2.3 Novartis International Eosinophilic Granulomatosis Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis International Eosinophilic Granulomatosis Product Portfolio
  12. 6.2.5 Novartis International Recent Developments
  13. 6.3 GlaxoSmithKline
  14. 6.3.1 GlaxoSmithKline Company Information
  15. 6.3.2 GlaxoSmithKline Business Overview
  16. 6.3.3 GlaxoSmithKline Eosinophilic Granulomatosis Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GlaxoSmithKline Eosinophilic Granulomatosis Product Portfolio
  18. 6.3.5 GlaxoSmithKline Recent Developments
  19. 6.4 Baxter
  20. 6.4.1 Baxter Company Information
  21. 6.4.2 Baxter Business Overview
  22. 6.4.3 Baxter Eosinophilic Granulomatosis Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Baxter Eosinophilic Granulomatosis Product Portfolio
  24. 6.4.5 Baxter Recent Developments
  25. 6.5 Amgen
  26. 6.5.1 Amgen Company Information
  27. 6.5.2 Amgen Business Overview
  28. 6.5.3 Amgen Eosinophilic Granulomatosis Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Amgen Eosinophilic Granulomatosis Product Portfolio
  30. 6.5.5 Amgen Recent Developments
  31. 6.6 AstraZeneca
  32. 6.6.1 AstraZeneca Company Information
  33. 6.6.2 AstraZeneca Business Overview
  34. 6.6.3 AstraZeneca Eosinophilic Granulomatosis Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AstraZeneca Eosinophilic Granulomatosis Product Portfolio
  36. 6.6.5 AstraZeneca Recent Developments
  37. 6.7 Pharmaceuticals Holdings
  38. 6.7.1 Pharmaceuticals Holdings Company Information
  39. 6.7.2 Pharmaceuticals Holdings Business Overview
  40. 6.7.3 Pharmaceuticals Holdings Eosinophilic Granulomatosis Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pharmaceuticals Holdings Eosinophilic Granulomatosis Product Portfolio
  42. 6.7.5 Pharmaceuticals Holdings Recent Developments
  43. 6.8 Genentech(Roche)
  44. 6.8.1 Genentech(Roche) Company Information
  45. 6.8.2 Genentech(Roche) Business Overview
  46. 6.8.3 Genentech(Roche) Eosinophilic Granulomatosis Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Genentech(Roche) Eosinophilic Granulomatosis Product Portfolio
  48. 6.8.5 Genentech(Roche) Recent Developments
  49. 6.9 DSM
  50. 6.9.1 DSM Company Information
  51. 6.9.2 DSM Business Overview
  52. 6.9.3 DSM Eosinophilic Granulomatosis Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 DSM Eosinophilic Granulomatosis Product Portfolio
  54. 6.9.5 DSM Recent Developments
  55. 6.10 Cephalon(Teva)
  56. 6.10.1 Cephalon(Teva) Company Information
  57. 6.10.2 Cephalon(Teva) Business Overview
  58. 6.10.3 Cephalon(Teva) Eosinophilic Granulomatosis Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Cephalon(Teva) Eosinophilic Granulomatosis Product Portfolio
  60. 6.10.5 Cephalon(Teva) Recent Developments
7 North America by Country
  1. 7.1 North America Eosinophilic Granulomatosis Sales by Country
  2. 7.1.1 North America Eosinophilic Granulomatosis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Eosinophilic Granulomatosis Sales by Country (2021-2026)
  4. 7.1.3 North America Eosinophilic Granulomatosis Sales Forecast by Country (2027-2032)
  5. 7.2 North America Eosinophilic Granulomatosis Market Size by Country
  6. 7.2.1 North America Eosinophilic Granulomatosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Eosinophilic Granulomatosis Market Size by Country (2021-2026)
  8. 7.2.3 North America Eosinophilic Granulomatosis Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Eosinophilic Granulomatosis Sales by Country
  2. 8.1.1 Europe Eosinophilic Granulomatosis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Eosinophilic Granulomatosis Sales by Country (2021-2026)
  4. 8.1.3 Europe Eosinophilic Granulomatosis Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Eosinophilic Granulomatosis Market Size by Country
  6. 8.2.1 Europe Eosinophilic Granulomatosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Eosinophilic Granulomatosis Market Size by Country (2021-2026)
  8. 8.2.3 Europe Eosinophilic Granulomatosis Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Eosinophilic Granulomatosis Sales by Country
  2. 9.1.1 Asia-Pacific Eosinophilic Granulomatosis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Eosinophilic Granulomatosis Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Eosinophilic Granulomatosis Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Eosinophilic Granulomatosis Market Size by Country
  6. 9.2.1 Asia-Pacific Eosinophilic Granulomatosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Eosinophilic Granulomatosis Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Eosinophilic Granulomatosis Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Eosinophilic Granulomatosis Sales by Country
  2. 10.1.1 South America Eosinophilic Granulomatosis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Eosinophilic Granulomatosis Sales by Country (2021-2026)
  4. 10.1.3 South America Eosinophilic Granulomatosis Sales Forecast by Country (2027-2032)
  5. 10.2 South America Eosinophilic Granulomatosis Market Size by Country
  6. 10.2.1 South America Eosinophilic Granulomatosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Eosinophilic Granulomatosis Market Size by Country (2021-2026)
  8. 10.2.3 South America Eosinophilic Granulomatosis Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Eosinophilic Granulomatosis Sales by Country
  2. 11.1.1 Middle East and Africa Eosinophilic Granulomatosis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Eosinophilic Granulomatosis Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Eosinophilic Granulomatosis Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Eosinophilic Granulomatosis Market Size by Country
  6. 11.2.1 Middle East and Africa Eosinophilic Granulomatosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Eosinophilic Granulomatosis Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Eosinophilic Granulomatosis Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Eosinophilic Granulomatosis Value Chain Analysis
  2. 12.1.1 Eosinophilic Granulomatosis Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Eosinophilic Granulomatosis Production Mode & Process
  7. 12.2 Eosinophilic Granulomatosis Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Eosinophilic Granulomatosis Distributors
  10. 12.2.3 Eosinophilic Granulomatosis Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst